Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003062215 | SCV003440796 | pathogenic | not provided | 2023-11-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser539*) in the VPS13A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13A are known to be pathogenic (PMID: 12404112, 21598378). This variant is present in population databases (rs758612012, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with choreoacanthocytosis (PMID: 12404112). ClinVar contains an entry for this variant (Variation ID: 2136781). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003485808 | SCV004238798 | likely pathogenic | Chorea-acanthocytosis | 2023-02-15 | criteria provided, single submitter | clinical testing |